Ocuphire Pharma, Inc. - Common Stock (OCUP)

Ocuphire Pharma acquires Opus Genetics, expanding its IRD gene therapy pipeline. The renamed company, Opus Genetics, will trade under "IRD" by late October 2024.

OCUP stock results show that Ocuphire Pharma missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.

These biotech stocks, lacking in profitability but seeding huge potential, should be on your watchlist.

OCUP stock results show that Ocuphire Pharma missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.

The Dow Jones index closed lower by over 150 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

OCUP stock results show that Ocuphire Pharma missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.

Although the health innovation space can be a risky environment, undervalued biotech stocks can take some of the edge off.

While many investors continue to chase after the latest trends, these underappreciated value stocks to buy could be the true winners.

Often the best investments are out-of-favor and trade at silly cheap valuations. Check out three such growth stocks with huge upside.

While investing in penny stocks carries a rough reputation (to put it nicely), these speculative entities just might surprise you.

While quality matters in the market, these best stocks under $10 to buy gives you some potential diamonds in the rough.

Although small-cap biotech stocks present high risks, if they hit one out of the park, the rewards can be astronomical.

Gainers NeoGames S.A. (NASDAQ: NGMS) shares climbed 113.3% to $27.38 as the company agreed to be acquired by Aristocrat Leisure Limited for $29.50 per share in cash.

Ocuphire Pharma Inc (NASDAQ: OCUP) was plunging over 22% at one point on Friday after the company announced it appointed Rick Rodgers to the role of interim CEO.

Gainers Mangoceuticals, Inc. (NASDAQ: MGRX) shares jumped 207% to $2.84. The company announced Thursday, that it's featured on Webull Corporate Communications Service Platform.

U.S. stocks traded mostly lower this morning, with the Nasdaq Composite dropping around 50 points on Friday. Following the market opening Friday, the Dow traded down 0.03% to 33,777.38 while the NASDAQ fell 0.43% to 12,008.96. The S&P 500, also fell, dropping, 0.18% to 4,122.44.